Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4477)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2023 (publication date) through Apr 10, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shoji Y, Koyanagi K, Kanamori K, Tajima K, Ogimi M, Yatabe K, Yamamoto M, Kazuno A, Nabeshima K, Nakamura K, Nishi T, Mori M. Current status and future perspectives for the treatment of resectable locally advanced esophagogastric junction cancer: A narrative review. World J Gastroenterol 2023; 29(24): 3758-3769 [PMID: 37426325 DOI: 10.3748/wjg.v29.i24.3758] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i24/3758.htm |
| Number | Citing Articles |
| 1 |
S. A. Domrachev, V. A. Lukyanchikov, N. E. Semenov, T. A. Shatokhin, O. Yu. Bogdanova, Z. A. Kulov. Combined Treatment for Locally Advanced Cardioesophageal Cancer in a Comorbid Patient with Internal Carotid Artery Stenosis. Russian Sklifosovsky Journal "Emergency Medical Care" 2025; 13(4): 748 doi: 10.23934/2223-9022-2024-13-4-748-755
|
| 2 |
Haiya Ou, Jiamei Zhuang, Mingwei Jian, Xinyi Zheng, Tingping Wu, Honghui Cheng, Rui Qian. Perioperative versus adjuvant chemotherapy for resectable gastric cancer: a meta-analysis of randomized controlled trials. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1432596
|
| 3 |
Shuo Guo, Fang-Fang Liu, Li Yuan, Wen-Qian Ma, Li-Mian Er, Qun Zhao. Subclassification scheme for adenocarcinomas of the esophagogastric junction and prognostic analysis based on clinicopathological features. World Journal of Gastrointestinal Oncology 2025; 17(4): 103455 doi: 10.4251/wjgo.v17.i4.103455
|
| 4 |
Zhenjiang Guo, Ning Wang, Guangyuan Zhao, Liqiang Du, Zhaobo Cui, Fangzhen Liu. Development and validation of a preoperative model for predicting positive proximal margins in adenocarcinoma of the esophagogastric junction and assessing safe margin distance. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1503728
|
| 5 |
Yoshiaki Shoji, Kohei Kanamori, Kazuo Koyanagi, Tetsuya Otsuka, Rie Nakashima, Kohei Tajima, Mika Ogimi, Yamato Ninomiya, Miho Yamamoto, Akihito Kazuno, Takayuki Nishi, Masaki Mori. Conversion surgery for esophageal and esophagogastric junction cancer. International Journal of Clinical Oncology 2024; 29(12): 1777 doi: 10.1007/s10147-024-02639-4
|
| 6 |
Rajika Jindani, Jorge Humberto Rodriguez-Quintero, Isaac Loh, Grace Ha, Justin Olivera, Justin Rosario, Roger Zhu, Mohamed K Kamel, Marc Vimolratana, Neel P Chudgar, Brendon M Stiles. Do socioeconomic factors impair uptake of neoadjuvant therapy for patients with locoregional oesophageal cancer?. European Journal of Cardio-Thoracic Surgery 2024; 67(1) doi: 10.1093/ejcts/ezae462
|
| 7 |
Johnn Henry Herrera Kok, Luigi Marano, Jan Willem van den Berg, Preethi Shetty, Yogesh Vashist, Laura Lorenzon, Beate Rau, Richard van Hillegersberg, Giovanni de Manzoni, Andrea Spallanzani, Won Jun Seo, Hiromi Nagata, Clarisse Eveno, Stefan Mönig, Karen van der Sluis, Leonardo Solaini, Bas PL. Wijnhoven, Francesco Puccetti, Mickael Chevallay, Eunju Lee, Domenico D'Ugo. Current trends in the management of Gastro-oEsophageal cancers: Updates to the ESSO core curriculum (ESSO-ETC-UGI-WG initiative). European Journal of Surgical Oncology 2024; 50(7): 108387 doi: 10.1016/j.ejso.2024.108387
|